Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-319105
Filing Date
2020-12-16
Accepted
2020-12-16 16:40:58
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.ARTAL TREASURY LTDINVUS ADVISORS, L.L.C.INVUS C.V.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. PASCAL MINNEMR. RAYMOND DEBBANESTICHTING ADMINISTRATIEKANTOOR

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 15 TO SCHEDULE 13D d68713dsc13da.htm SC 13D/A 250250
2 EXHIBIT 18 d68713dex9918.htm EX-99.18 18618
  Complete submission text file 0001193125-20-319105.txt   271077
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Subject) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 201392918
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 (212) 371-1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

EIN.: 830359143
Type: SC 13D/A